Local ablative therapies, including surgery or stereotactic radiotherapy (SABR), are
becoming an integral component in the treatment of oligometastatic disease in non–small …

Surgical care for early stage non–small-cell lung cancer continuously evolves with new
procedures, techniques and care pathways. The most obvious recent change was the …

Objective: To investigate the association between operative time and postoperative
outcomes. Background: The association between operative time and morbidity after …

Simple Summary Video-assisted thoracoscopic surgery (VATS) and robotic-assisted
thoracoscopic surgery (RATS) are known to be safe and efficient surgical procedures to treat …

Background Lung cancer is the most common cause of death among all types of cancer in
Germany, with an annual death rate of 45 000 patients. Over the past 15 years, innovations …

Introduction Recent trials have reported promising results with the addition of
immunotherapy to chemotherapy for patients with locally advanced NSCLC, but in practice …

Simple Summary Neoadjuvant immunotherapy is a novel approach for lung cancer patients
in stages where curative intent treatment is possible. The rationale is a based on the idea …

Background Enhanced recovery after surgery (ERAS) has been associated with improved
perioperative outcomes after thoracic surgery; however, the impact on long-term opioid use …

OBJECTIVES Recent randomized data support the perioperative benefits of minimally
invasive surgery (MIS) for non-small-cell lung cancer (NSCLC). Its utility for cT4 tumours …

OBJECTIVES Although adjuvant systemic therapy (AT) has demonstrated improved survival
in patients with resected non-small-cell lung cancer (NSCLC), it remains underutilized …